Analysts Set Doximity, Inc. (NASDAQ:DOCS) Price Target at $67.42

Doximity, Inc. (NASDAQ:DOCS) has been given an average recommendation of “Moderate Buy” by the twenty-two analysts that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating, ten have given a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $68.1579.

A number of research analysts recently commented on DOCS shares. The Goldman Sachs Group set a $64.00 price target on Doximity and gave the stock a “sell” rating in a report on Wednesday. Truist Financial boosted their price target on Doximity from $52.00 to $61.00 and gave the stock a “hold” rating in a report on Thursday, July 17th. Needham & Company LLC boosted their price target on Doximity from $67.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, August 8th. KeyCorp upped their price objective on Doximity from $65.00 to $70.00 and gave the stock an “overweight” rating in a report on Monday, July 14th. Finally, Robert W. Baird upped their price objective on Doximity from $75.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, September 11th.

Insider Transactions at Doximity

In other news, Director Kira Scherer Wampler sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the sale, the director directly owned 16,618 shares of the company’s stock, valued at $948,721.62. This represents a 10.74% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the sale, the director directly owned 3,221 shares in the company, valued at $241,575. This trade represents a 86.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 37,000 shares of company stock valued at $2,581,880 in the last ninety days. Corporate insiders own 31.30% of the company’s stock.

Institutional Trading of Doximity

Hedge funds and other institutional investors have recently bought and sold shares of the stock. SG Americas Securities LLC bought a new position in Doximity in the 1st quarter valued at $65,702,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Doximity by 130.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock valued at $114,133,000 after acquiring an additional 1,113,076 shares during the last quarter. Franklin Resources Inc. grew its position in Doximity by 53.9% in the 2nd quarter. Franklin Resources Inc. now owns 3,162,593 shares of the company’s stock valued at $193,993,000 after acquiring an additional 1,108,162 shares during the last quarter. Vanguard Group Inc. grew its position in Doximity by 8.8% in the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock valued at $707,646,000 after acquiring an additional 990,923 shares during the last quarter. Finally, Holocene Advisors LP bought a new position in shares of Doximity during the 2nd quarter worth $44,983,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Stock Up 2.0%

Doximity stock opened at $72.06 on Friday. The business has a 50-day simple moving average of $67.00 and a two-hundred day simple moving average of $60.64. The company has a market cap of $13.50 billion, a P/E ratio of 72.06, a P/E/G ratio of 4.10 and a beta of 1.37. Doximity has a 52-week low of $40.87 and a 52-week high of $85.21.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The company’s quarterly revenue was up 15.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Research analysts anticipate that Doximity will post 0.99 EPS for the current fiscal year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.